ClinicalTrials.Veeva

Menu

Concomitant Tricuspid Repair in Patients With Left Heart Surgery

N

Nanjing Medical University

Status

Not yet enrolling

Conditions

Cardiopulmonary Bypass
Mitral Regurgitation
Tricuspid Regurgitation

Treatments

Device: Tricuspid repair

Study type

Interventional

Funder types

Other

Identifiers

NCT05595187
JPH-2022

Details and patient eligibility

About

Tricuspid regurgitation is common in patients with severe left heart diseases, such as degenerative mitral regurgitation. However, the evidence base is insufficient to inform a decision about whether to perform concomitant tricuspid-valve repair during left heart surgery in patients who have mild tricuspid regurgitation. To inform decision making, we will conduct a multicenter, randomized trial to assess the benefits and risks of tricuspid-valve repair at the time of left heart diseases in patients with mild tricuspid regurgitation who were undergoing surgery for left heart surgery.

Enrollment

400 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients undergoing left heart valve surgery with mild tricuspid regurgitation;
  2. Patients aged 18-80 years;
  3. Agree to participate in this study and sign the informed consent form.

Exclusion criteria

  1. Infective endocarditis within 3 months;
  2. Primary tricuspid regurgitation;
  3. Isolated tricuspid regurgitation
  4. Lactating women and suspected pregnant or pregnant women;
  5. Patients with mental disorders, drug and alcohol dependence;
  6. Those who participated in other clinical trials one month before the trial;
  7. Refusal to participate in this study without informed consent.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

400 participants in 2 patient groups

Tricuspid repair
Experimental group
Description:
Tricuspid repair techniques included suture placement and the type of prosthetic annuloplasty with specified the use of an approved rigid, incomplete, nonplanar, and undersized (ranging 26, 28, or 30, 32, 34 mm) ring.
Treatment:
Device: Tricuspid repair
Blank control
No Intervention group

Trial contacts and locations

1

Loading...

Central trial contact

Hong Liu, MD; Yong-feng Shao, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems